Product NDC: | 50236-001 |
Proprietary Name: | Visudyne |
Non Proprietary Name: | verteporfin for injection |
Active Ingredient(s): | 15 mg/1 & nbsp; verteporfin for injection |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50236-001 |
Labeler Name: | QLT Ophthalmics, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021119 |
Marketing Category: | NDA |
Start Marketing Date: | 20000412 |
Package NDC: | 50236-001-15 |
Package Description: | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (50236-001-15) |
NDC Code | 50236-001-15 |
Proprietary Name | Visudyne |
Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (50236-001-15) |
Product NDC | 50236-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | verteporfin for injection |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20000412 |
Marketing Category Name | NDA |
Labeler Name | QLT Ophthalmics, Inc. |
Substance Name | VERTEPORFIN |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Photoabsorption [MoA],Photoenhancer [EPC],Photosensitizing Activity [PE] |